Cargando…

Cardiovascular effects of cholecalciferol treatment in dialysis patients – a randomized controlled trial

BACKGROUND: Patients on chronic dialysis are at increased risk of vitamin D deficiency. In observational studies plasma 25-hydroxyvitamin D (p-25(OH) D) levels are inversely correlated with plasma BNP and adverse cardiovascular outcomes. Whether a causal relation exists has yet to be established. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mose, Frank H, Vase, Henrik, Larsen, Thomas, Kancir, Anne SP, Kosierkiewic, Renata, Jonczy, Bartlomiej, Hansen, Annebirthe B, Oczachowska-Kulik, Anna E, Thomsen, Ingrid M, Bech, Jesper N, Pedersen, Erling B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994388/ https://www.ncbi.nlm.nih.gov/pubmed/24661355 http://dx.doi.org/10.1186/1471-2369-15-50

Ejemplares similares

Effect of furosemide on body composition and urinary proteins that mediate tubular sodium and sodium transport—A randomized controlled trial
por: Mose, Frank Holden, et al.
Publicado: (2020)

Effect of paricalcitol on renin and albuminuria in non-diabetic stage III-IV chronic kidney disease: a randomized placebo-controlled trial
por: Larsen, Thomas, et al.
Publicado: (2013)

Abnormal increase in urinary aquaporin-2 excretion in response to hypertonic saline in essential hypertension
por: Graffe, Carolina Cannillo, et al.
Publicado: (2012)

Abnormal urinary excretion of NKCC2 and AQP2 in response to hypertonic saline in chronic kidney disease: an intervention study in patients with chronic kidney disease and healthy controls
por: Jensen, Janni M, et al.
Publicado: (2014)

Increased renal sodium absorption by inhibition of prostaglandin synthesis during fasting in healthy man. A possible role of the epithelial sodium channels
por: Lauridsen, Thomas G, et al.
Publicado: (2010)

Effect of volume expansion with hypertonic- and isotonic saline and isotonic glucose on sodium and water transport in the principal cells in the kidney
por: Jensen, Janni M, et al.
Publicado: (2013)

Effect of vasopressin antagonism on renal handling of sodium and water and central and brachial blood pressure during inhibition of the nitric oxide system in healthy subjects
por: Al Therwani, Safa, et al.
Publicado: (2014)

Effect of tolvaptan on renal water and sodium excretion and blood pressure during nitric oxide inhibition: a dose-response study in healthy subjects
por: Al Therwani, Safa, et al.
Publicado: (2017)

The effect of sodium nitrite infusion on renal function, brachial and central blood pressure during enzyme inhibition by allopurinol, enalapril or acetazolamide in healthy subjects: a randomized, double-blinded, placebo-controlled, crossover study
por: Rosenbaek, Jeppe B., et al.
Publicado: (2018)

Efficacy and safety of body weight-adapted oral cholecalciferol substitution in dialysis patients with vitamin D deficiency
por: Zitt, Emanuel, et al.
Publicado: (2015)

The Influence of Different Cholecalciferol Supplementation Regimes on 25(OH) Cholecalciferol, Calcium and Parathyroid Hormone after Bariatric Surgery
por: Smelt, Hendrika J.M., et al.
Publicado: (2019)

Prednisolone treatment in acute interstitial nephritis (PRAISE) – protocol for the randomized controlled trial
por: Mose, Frank H., et al.
Publicado: (2021)

Cholecalciferol or Calcifediol in the Management of Vitamin D Deficiency
por: Sosa Henríquez, Manuel, et al.
Publicado: (2020)

Placebo-controlled, randomized clinical trial of high-dose cholecalciferol in renal dialysis patients: effect on muscle strength and quality of life
por: Singer, Richard, et al.
Publicado: (2018)

Abnormal function of the vasopressin-cyclic-AMP-aquaporin2 axis during urine concentrating and diluting in patients with reduced renal function. A case control study
por: Pedersen, Erling B, et al.
Publicado: (2010)

Evaluation of one-alpha-hydroxy-cholecalciferol alone or in combination with cholecalciferol in Ca—P deficiency diets on development of tibial dyschondroplasia in broiler chickens
por: Landy, Nasir, et al.
Publicado: (2018)

Action of cholecalciferol and alpha-tocopherol on Staphylococcus aureus efflux pumps
por: Tintino, Saulo R., et al.
Publicado: (2016)

Cholecalciferol and Cancer: Is It a Big D(3)-eal?
por: Wickham, Rita
Publicado: (2012)

Disparity in cholecalciferol content of commercial preparations available in India
por: Khadgawat, Rajesh, et al.
Publicado: (2013)

Successful cholecalciferol desensitisation in a case of delayed hypersensitivity
por: Anantharajah, Anthea, et al.
Publicado: (2019)

The role of cholecalciferol deficiency in the pathogenesis of polycystic ovary syndrome
por: Safi, Aigul, et al.
Publicado: (2020)

Cholecalciferol level and its impact on COVID-19 patients
por: Saeed, Mohammed Abdel Monem, et al.
Publicado: (2022)

Cholecalciferol supplementation and angiogenic markers in chronic kidney disease
por: Kaur, Jaskiran, et al.
Publicado: (2022)

Nocturnal blood pressure decrease in patients with chronic kidney disease and in healthy controls – significance of obstructive sleep apnea and renal function
por: Hornstrup, Bodil G, et al.
Publicado: (2018)

The stop-feed effect of cholecalciferol (vitamin D(3)) and the efficacy of brodifacoum combined with cholecalciferol in Y139C-resistant Norway rats (Rattus norvegicus)
por: Klemann, Nicole, et al.
Publicado: (2023)

Effect of Cholecalciferol Overdosage on Pregnancy Outcome in White Albino Mice
por: Ogamba, JO, et al.
Publicado: (2011)

Long-term high-dose cholecalciferol in patients with heavy proteinuria
por: Singer, Richard F.
Publicado: (2011)

Evaluation of Relative Bioavailability of 25-Hydroxycholecalciferol to Cholecalciferol for Broiler Chickens
por: Han, J. C., et al.
Publicado: (2016)

Pharmacokinetic Drug Interaction Between Raloxifene and Cholecalciferol in Healthy Volunteers
por: Lee, Hae Won, et al.
Publicado: (2022)

Hemodynamic, renal and hormonal effects of lung protective ventilation during robot-assisted radical prostatectomy, analysis of secondary outcomes from a randomized controlled trial
por: Høyer, Sidse, et al.
Publicado: (2021)

Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial
por: Mathiassen, Ole N., et al.
Publicado: (2016)

Urine concentration ability is reduced to the same degree in adult dominant polycystic kidney disease compared with other chronic kidney diseases in the same CKD-stage and lower THAN in healthy control subjects - a CASE control study
por: Malmberg, M. H., et al.
Publicado: (2020)

A Comparison of Urine Dilution Ability between Adult Dominant Polycystic Kidney Disease, Other Chronic Kidney Diseases, and Healthy Control Subjects: A Case-Control Study
por: Malmberg, M. H., et al.
Publicado: (2020)

Effect of tolvaptan on renal handling of water and sodium, GFR and central hemodynamics in autosomal dominant polycystic kidney disease during inhibition of the nitric oxide system: a randomized, placebo-controlled, double blind, crossover study
por: Al Therwani, Safa, et al.
Publicado: (2017)

A randomized controlled trial of cholecalciferol supplementation in patients on maintenance hemodialysis
por: Bansal, Beena, et al.
Publicado: (2014)

An in-vitro–in-vivo model for the transdermal delivery of cholecalciferol for the purposes of rodent management
por: Davies, J., et al.
Publicado: (2015)

Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE)
por: Camu, William, et al.
Publicado: (2019)

Comparison of Bioavailability of 1α-Hydroxycholecalciferol and Cholecalciferol in Broiler Chicken Diets
por: Wang, Jianguo, et al.
Publicado: (2016)

Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women
por: Sosa‐Henríquez, Manuel, et al.
Publicado: (2022)

Effects of High Doses of Cholecalciferol in Normal Subjects: A Randomized Double-Blinded, Placebo-Controlled Trial
por: Nygaard, Birgitte, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qm78oeqan5nblhr736bg6a7p5o